The effect of evocalcet on vagus nerve activity of the gastrointestinal tract in miniature pigs.
Evocalcet is a novel calcimimetic agent with fewer gastrointestinal (GI) adverse effects compared to cinacalcet. Although it is thought that cinacalcet induces GI side effects through the direct stimulation of the calcium receptor (CaR) expressed in the GI tract, the differences in the direct stimul...
Main Authors: | Shin Tokunaga, Takehisa Kawata |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0245785 |
Similar Items
-
Evocalcet prevents ectopic calcification and parathyroid hyperplasia in rats with secondary hyperparathyroidism.
by: Mariko Sakai, et al.
Published: (2020-01-01) -
A novel calcimimetic agent, evocalcet (MT-4580/KHK7580), suppresses the parathyroid cell function with little effect on the gastrointestinal tract or CYP isozymes in vivo and in vitro.
by: Takehisa Kawata, et al.
Published: (2018-01-01) -
The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract
by: Bruno Bonaz, et al.
Published: (2017-11-01) -
A novel calcimimetic evocalcet for the management of secondary hyperparathyroidism with little effect on the gastrointestinal tract and cyp isozymes in vivo and in vitro
by: Lilit V. Egshatyan
Published: (2020-06-01) -
Efferent activity in the vagus nerves in response to gastrointestinal distensions
by: Salih, A. A.
Published: (1980)